|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 211 - 240 of 367 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Tilamir 250 mg, 500 mg, 750 mg, 1000 mg tabletti, kalvopäällysteinen SPC 2022-02-01
|
PL
|
Resepti
|
Timosan 1 mg-g silmägeeli SPC 2022-02-15
|
PL
|
Resepti
|
Timosan 1 mg-g silmägeeli, kerta-annospakkaus SPC 2021-12-17
|
PL
|
Resepti
|
Tiogiva 18 mikrog inhalaatiojauhe, kapseli, kova SPC 2023-05-03
|
PL
|
Resepti
|
Tiotropium STADA 18 mikrog inhalaatiojauhe, kapseli, kova SPC 2024-06-27
|
PL
|
Resepti
|
Tisamid 500 mg tabletti SPC 2023-01-13
|
PL
|
Resepti
|
Tisseel liuokset kudosliimaa varten SPC 2021-06-18
|
|
|
European Medicines Agency's website: Tivicay - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Tizagelan 2 mg, 4 mg tabletti SPC 2023-05-30
|
PL
|
Resepti
|
Tizanidin Orion 2 mg, 4 mg tabletti SPC 2022-11-07
|
|
|
European Medicines Agency's website: Tizveni - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
TOBI 300 mg-5 ml sumutinliuos SPC 2023-08-23
|
|
|
European Medicines Agency's website: Tobi Podhaler - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Tobramycin Pari - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Tobrasone 3 mg-ml + 1 mg-ml silmätipat, suspensio SPC 2022-06-03
|
PL
|
Resepti
|
Toctino 10 mg ja 30 mg kapseli pehmeä SPC 2023-11-27
|
|
|
European Medicines Agency's website: Tofidence - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Toilax 2 mg-ml peräruiskesuspensio SPC 2022-05-31
|
PL
|
Itsehoito
|
Toilax 5 mg enterotabletti SPC 2022-12-29
|
PL
|
Itsehoito
|
Toilax yhdistelmäpakkaus, enterotabletti ja peräruiskesuspensio SPC 2022-05-31
|
PL
|
Resepti
|
Tolerak 40 mg-g emulsiovoide SPC 2024-06-28
|
PL
|
Resepti
|
Tolterodin Mylan 4 mg depotkapseli, kova SPC 2012-02-13.doc
|
PL
|
Resepti
|
Tolterodin ratiopharm 4 mg depotkapseli, kova SPC 2020-08-20
|
PL
|
Resepti
|
Tolterodin SanoSwiss 4 mg depotkapseli, kova SPC 2022-06-27
|
PL
|
Resepti
|
Tolterodin Viatris 2 mg, 4 mg depotkapseli, kova SPC 2022-02-13
|
PL
|
Resepti
|
Tolterodine Sandoz 4 mg depotkapseli, kova SPC 2021-01-26
|
|
|
European Medicines Agency's website: Tolucombi - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Tolura - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Tolvaptan Accord - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Tolvon 10 mg, 30 mg, 60 mg tabletti, kalvopäällysteinen SPC 2021-04-27
|
|
| |